Dr Reddy's, Sun Pharma recall products in US for manufacturing issues

Dr Reddy's Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose, while Sun Pharma is recalling 14,064 cartons of a medication to treat erosive esophagitis or heartburn caused by GERD.

PTIUpdated: Sunday, December 04, 2022, 12:27 PM IST
article-image
Dr Reddy's, Sun Pharma recall products in US for manufacturing issues | File/ Representative image

Drug majors Dr Reddy's Laboratories and Sun Pharma are recalling different products in the US market for manufacturing issues, according to the US Food and Drug Administration.

Dr. Reddy

As per the enforcement report by the US health regulator, the US-based arm of Dr Reddy's Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose. It is recalling 25,176 cartons of 30-count tablets and 22,968 cartons of 20-count tablets.

According to USFDA, Dr Reddy's Laboratories is recalling the affected lot due to "failed stability specifications".

New Jersey-based Dr Reddy's Laboratories, Inc initiated the Class III recall on November 21 this year. As per USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".

Sun Pharma

The health regulator further said the US-based arm of Sun Pharma is recalling 14,064 cartons of a medication to treat erosive esophagitis or heartburn caused by gastroesophageal reflux disease (GERD). The company is recalling the affected lot, produced at its Mohali plant, due to "discoloration", it added.

Sun Pharmaceutical Industries Inc commenced the Class II voluntary recall in the US on July 25 this year. As per USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

US generic drug market

According to industry estimates, the US generic drug market was estimated at around USD 115.2 billion in 2019. It is the largest market for pharmaceutical products.

(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Tech layoffs: Google has sacked its mental health team, and it can backfire

Tech layoffs: Google has sacked its mental health team, and it can backfire

Adani fiasco pushes India out of top 5 countries by market capitalisation

Adani fiasco pushes India out of top 5 countries by market capitalisation

Powergrid Corporation of India approves 2nd interim dividend payment of Rs 5 per share

Powergrid Corporation of India approves 2nd interim dividend payment of Rs 5 per share

Earnings 2023 LIVE: Sun Pharma net profit at Rs 2,180.75 cr, Godrej Consumer Products net profit at...

Earnings 2023 LIVE: Sun Pharma net profit at Rs 2,180.75 cr, Godrej Consumer Products net profit at...

Here are PNBs hiked lending rates for all tenors

Here are PNBs hiked lending rates for all tenors